Latest Payments News

Page 124 of 357
Clean TeQ Water Limited reported a reduced loss of $2.8 million for FY25 and increased its stake in Go2Lithium Inc to 60%, marking a strategic shift as it advances water treatment and critical metals recovery projects worldwide.
Victor Sage
Victor Sage
28 Aug 2025
Sparc Technologies reported a narrower FY25 loss alongside progress in green hydrogen and graphene additive projects, supported by government grants and a successful capital raise.
Victor Sage
Victor Sage
28 Aug 2025
Steadfast Group Limited has announced a fully franked ordinary dividend of AUD 0.117 per share for the half-year ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 2.5% discount.
Claire Turing
Claire Turing
28 Aug 2025
CTI Logistics Limited has announced a fully franked ordinary dividend of AUD 0.055 per share for the half-year ending June 2025, offering shareholders reinvestment and bonus security plans with attractive discounts.
Victor Sage
Victor Sage
28 Aug 2025
CTI Logistics reported a modest revenue increase for FY2025 but faced a notable drop in net profit, maintaining steady dividends despite earnings pressure.
Victor Sage
Victor Sage
28 Aug 2025
NeuroScientific Biopharmaceuticals reported a $1.85 million loss for FY25, driven by reduced R&D incentives and increased development costs following its acquisition of StemSmart™ technology. The company is advancing clinical programs, including a Special Access Scheme for Crohn’s disease.
Ada Torres
Ada Torres
28 Aug 2025
Algorae Pharmaceuticals reported a 62% reduction in net loss for FY2025, driven by R&D tax credits and cost efficiencies, while making significant strides in its AI drug discovery platform and therapeutic candidates.
Ada Torres
Ada Torres
28 Aug 2025
Global X Management (AUS) Limited has announced updated estimated distribution amounts for three of its ETFs listed on the ASX AQUA Market for the period ending 31 August 2025, alongside key dates for investors to note.
Claire Turing
Claire Turing
28 Aug 2025
Argenica Therapeutics reported a 34% revenue increase driven by R&D incentives but saw losses widen by 31% due to intensified clinical trial activity. The company is progressing its ARG-007 Phase 2 stroke trial and engaging with the FDA to lift a clinical hold.
Victor Sage
Victor Sage
28 Aug 2025
Mad Paws Holdings reported a $12.27 million loss for FY25, deepening from last year, as it divests its Pet Chemist business and agrees to a $62 million acquisition by Rover Group.
Sophie Babbage
Sophie Babbage
28 Aug 2025
Betashares Capital Ltd has released estimated monthly distribution figures for 17 of its ETFs for the August 2025 period, setting key dates for investors ahead of final payouts.
Claire Turing
Claire Turing
28 Aug 2025
Icetana Limited posted a $2.9 million net loss for FY2025, with revenues down 49% due to lower non-recurring sales, while recurring SaaS income grew. The company secured a $3.6 million strategic partnership with SoftBank Robotics, strengthening its foothold in Japan.
Sophie Babbage
Sophie Babbage
28 Aug 2025